SMTL ID : 5vo6.1

CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRIDAZINE INHIBITOR

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.65 Å

Oligo State

monomer

Ligands

1 x 9J4: 4-{[(1R,3S)-3-amino-2,2,3-trimethylcyclopentyl]amino}-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide(Non-covalent)

9J4.1: 16 residues within 4Å: Chain A: L.21, G.22, V.29, A.46, V.77, M.95, E.96, Y.97, L.98, P.99, G.101, C.102, R.146, N.147, L.149, D.160 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.21, A:L.21, A:L.21, A:V.29, A:A.46, A:Y.97, A:L.149, A:D.160 Hydrogen bonds: A:E.96, A:L.98, A:R.146 Water bridges: A:D.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hynes, J. et al., Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors. Bioorg. Med. Chem. Lett. (2017)

Release Date

2017-05-31

Peptides

Tyrosine-protein kinase JAK3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK3

Related Entries With Identical Sequence